Catalyst Wire Dossier Catalyst Wire Dossier

Lumasiran

lumasiran · Alnylam Pharmaceuticals
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Lumasiran, covering 2020-01-30 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Lumasiran in Hyperoxalaemic Patients on Haemodialysis [Phase 2]

See pricing